Impact of Disease Modifying Therapy on Quality of Life in Pediatric Multiple Sclerosis

被引:0
|
作者
Doslea, A.
Parker, M.
Suslovic, W.
Ball, L.
Fleming, M.
Sady, M.
Wells, E.
Khan, I
机构
关键词
Demyelinating Disorders;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
26
引用
收藏
页码:S52 / S52
页数:1
相关论文
共 50 条
  • [41] Multiple sclerosis: disease modifying therapy and the human leukocyte antigen
    Werneck, Lineu Cesar
    Lorenzoni, Paulo Jose
    Kamoi Kay, Claudia Suemi
    Scola, Rosana Herminia
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2018, 76 (10) : 697 - 704
  • [42] Disease modifying therapy use in multiple sclerosis patients with comorbidities
    Conway, D. S.
    Planchon, S. M.
    Ontaneda, D.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 878 - 878
  • [43] ORAL DISEASE MODIFYING THERAPY FOR MULTIPLE SCLEROSIS; IS THIS THE NEW NORMAL?
    Johnson, B. H.
    VALUE IN HEALTH, 2015, 18 (03) : A290 - A291
  • [44] Multiple sclerosis Diagnosis, disease-modifying therapy and prognosis
    Travers, Brett S.
    Tsang, Benjamin K-T
    Barton, Joshua L.
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2022, 51 (04) : 199 - 206
  • [45] Breastfeeding and Disease-Modifying Therapy for Multiple Sclerosis Reply
    Hellwig, Kerstin
    Langer-Gould, Annette M.
    JAMA NEUROLOGY, 2016, 73 (04) : 480 - 481
  • [46] Disease modifying therapy for multiple sclerosis: Increasing availability in the UK
    Noori, MA
    Sharief, MK
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (10): : 1456 - 1457
  • [47] Disease-modifying therapy aids cognition in multiple sclerosis
    Maria Pia Amato
    Lauren B. Krupp
    Nature Reviews Neurology, 2020, 16 : 525 - 526
  • [48] Disease-modifying therapy aids cognition in multiple sclerosis
    Amato, Maria Pia
    Krupp, Lauren B.
    NATURE REVIEWS NEUROLOGY, 2020, 16 (10) : 525 - 526
  • [49] Adherence of Adolescents to Multiple Sclerosis Disease-Modifying Therapy
    Thannhauser, Jennifer E.
    Mah, Jean K.
    Metz, Luanne M.
    PEDIATRIC NEUROLOGY, 2009, 41 (02) : 119 - 123
  • [50] Vitamin D as disease-modifying therapy for multiple sclerosis?
    Lincoln, Matthew R.
    Schneider, Raphael
    Oh, Jiwon
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (07) : 691 - 693